Henry Schein (HSIC) Expected to Announce Earnings on Monday

Henry Schein (NASDAQ:HSIC) will likely be announcing its Q1 2025 earnings results before the market opens on Monday, May 5th. Analysts expect Henry Schein to post earnings of $1.11 per share and revenue of $3.24 billion for the quarter. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS and its FY25 guidance at $4.80-4.94 EPS.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.66 earnings per share. On average, analysts expect Henry Schein to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Henry Schein Price Performance

Shares of HSIC opened at $65.30 on Friday. Henry Schein has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The firm has a market capitalization of $8.00 billion, a PE ratio of 26.87, a PEG ratio of 2.13 and a beta of 0.84. The company’s 50-day moving average is $68.01 and its 200-day moving average is $71.59. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Barrington Research reiterated an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company began coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price on the stock. StockNews.com lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $80.20.

Insider Buying and Selling at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.